|
| The American Academy of Neurology has issued a new guideline recommending the most effective treatments to help people with Parkinson's disease who experience sleep, constipation, and sexual problems, which are common but often underrecognized symptoms. The guideline is published in the March 16, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology...
03/16/2010
|
|
| Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal Disease Models & Mechanisms...
03/12/2010
|
|
| Researchers have new insight into the relationship between Parkinson's disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson's disease...
03/11/2010
|
|
| Since 2000, the foundation has awarded over 175 million dollars to Parkinson's drug development research around the world, including at Karolinska Institutet. Michael J. Fox is to receive his honorary doctorate on 5 March from Associate Professor and Dean Clara H. Gumpert representing the Board of Research, which selects the honorary doctors at Karolinska Institutet...
03/08/2010
|
|
| Psychosurgery is making a comeback. Recently published case series have shown encouraging results of so-called deep brain stimulation (DBS) in treatment-resistant obsessive-compulsive disorder, depressive disorders, and Tourette syndrome...
03/05/2010
|
|
| Scientists are beginning to find out why people with Parkinson's disease often feel socially awkward. Parkinson's patients find it harder to recognize expressions of emotion in other people's faces and voices, report two studies published by the American Psychological Association...
03/04/2010
|
|
| For his work contributing to a potential new treatment approach for Parkinson's disease, the Michael J. Fox Foundation (MJFF) for Parkinson's Research has awarded a $500,000 grant to a neuroscientist at the Mayo Clinic campus in Florida. The researcher, Matthew Farrer, Ph.D...
03/03/2010
|
|
| Scientists at the Queensland Brain Institute have uncovered a vital clue into how the brain is wired, which could eventually steer research into nervous system disorders such as Parkinson's disease and cognitive disorders including autism. It's long been known that growing nerve fibres, also known as axons, must make connections in the brain for it to function properly...
03/03/2010
|
|
| Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease. The findings appear in the March 1 issue of the Journal of Immunology, a leading scientific journal in the field of immunology...
03/02/2010
|
|
| Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD...
02/23/2010
|
|
| For years, biologists have wondered how it is possible that not every person who carries a mutated gene expresses the trait or condition associated with the mutation. This common but poorly understood phenomenon, known as incomplete penetrance, exists in a wide range of organisms, including humans...
02/18/2010
|
|
| New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a study released that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. The research involved 136,474 people who did not have Parkinson's disease at the beginning of the research...
02/18/2010
|
|
| A new study from the National Institutes of Health sheds light on the functions of two proteins related to Parkinson's disease, called parkin and PINK1...
02/16/2010
|
|
| Amicus Therapeutics (Nasdaq: FOLD) announced additional positive preliminary data from its ongoing Phase 2 extension study of its investigational drug Amigalâ„¢ (migalastat HCl) for Fabry disease at the Lysosomal Disease Network WORLD Symposium in Miami, Florida...
02/12/2010
|
|
| A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate...
02/10/2010
|
